BACKGROUND: Measurement of concentrations of acute-phase proteins (APPs) is used as an aid in the diagnosis of a variety of diseases in animals. OBJECTIVE: To determine the concentration of APPs in dogs with steroid responsive meningitis-arteritis (SRMA) and other neurologic diseases. ANIMALS: One hundred and thirty-three dogs with neurologic diseases, 6 dogs with sepsis, and 8 healthy dogs were included in the study. Thirty-six dogs had SRMA (31 of which had monitoring), 14 dogs had other meningoencephalitides (ME), 32 had disk disease (IVDD/DLSS), 26 had tumors affecting the central nervous system (TCNS), and 25 had idiopathic epilepsy (IE). METHODS: Prospective, observational study: C-reactive protein (CRP), alpha(2)-macroglobulin (AMG), and albumin concentrations were determined in the serum or plasma. CRP was also measured in the cerebrospinal fluid. RESULTS: Serum CRP was significantly higher in dogs with SRMA (x=142 microg/mL+/-75) and sepsis (x=114 microg/mL+/-67) in comparison with dogs with other neurologic diseases (x=2.3-21 microg/mL; P< .001). There was no significant difference detected in AMG between groups. Serum albumin concentration was significantly lower (P< .01) in dogs with SRMA (x=3.2 g/dL+/-0.41) than in other groups (x=3.6-3.9 g/dL). Serum CRP concentration of SRMA dogs correlated with alkaline phosphatase levels (r=0.515, P= .003). CONCLUSIONS AND CLINICAL IMPORTANCE: CRP concentrations in serum are useful in diagnosis of dogs with SRMA. Serum CRP could be used as a monitoring parameter in treatment management of these dogs.
BACKGROUND: Measurement of concentrations of acute-phase proteins (APPs) is used as an aid in the diagnosis of a variety of diseases in animals. OBJECTIVE: To determine the concentration of APPs in dogs with steroid responsive meningitis-arteritis (SRMA) and other neurologic diseases. ANIMALS: One hundred and thirty-three dogs with neurologic diseases, 6 dogs with sepsis, and 8 healthy dogs were included in the study. Thirty-six dogs had SRMA (31 of which had monitoring), 14 dogs had other meningoencephalitides (ME), 32 had disk disease (IVDD/DLSS), 26 had tumors affecting the central nervous system (TCNS), and 25 had idiopathic epilepsy (IE). METHODS: Prospective, observational study: C-reactive protein (CRP), alpha(2)-macroglobulin (AMG), and albumin concentrations were determined in the serum or plasma. CRP was also measured in the cerebrospinal fluid. RESULTS: Serum CRP was significantly higher in dogs with SRMA (x=142 microg/mL+/-75) and sepsis (x=114 microg/mL+/-67) in comparison with dogs with other neurologic diseases (x=2.3-21 microg/mL; P< .001). There was no significant difference detected in AMG between groups. Serum albumin concentration was significantly lower (P< .01) in dogs with SRMA (x=3.2 g/dL+/-0.41) than in other groups (x=3.6-3.9 g/dL). Serum CRP concentration of SRMAdogs correlated with alkaline phosphatase levels (r=0.515, P= .003). CONCLUSIONS AND CLINICAL IMPORTANCE: CRP concentrations in serum are useful in diagnosis of dogs with SRMA. Serum CRP could be used as a monitoring parameter in treatment management of these dogs.
Authors: Kimberly M Anderson; C Jane Welsh; Colin Young; Gwendolyn J Levine; Sharon C Kerwin; C Elizabeth Boudreau; Ismael Reyes; Armando Mondragon; John F Griffin; Noah D Cohen; Jonathan M Levine Journal: J Neurotrauma Date: 2015-07-17 Impact factor: 5.269
Authors: Christian Günther; Frank Steffen; Daniela S Alder; Laura Beatrice; Caroline Geigy; Katrin Beckmann Journal: Vet Rec Date: 2020-02-21 Impact factor: 2.695
Authors: Sarah A Moore; Mi Young Kim; Arianna Maiolini; Andrea Tipold; Michael J Oglesbee Journal: Vet Immunol Immunopathol Date: 2011-11-02 Impact factor: 2.046
Authors: Michelle B Christensen; Rebecca Langhorn; Amelia Goddard; Eva B Andreasen; Elena Moldal; Asta Tvarijonaviciute; Jolle Kirpensteijn; Sabrina Jakobsen; Frida Persson; Mads Kjelgaard-Hansen Journal: Can Vet J Date: 2014-02 Impact factor: 1.008
Authors: Rafaela Furioso Ferreira; Rosangela Locatelli Dittrich; Isabelle Bay Zimmermann; Blanka Beer Ljubic; Vladimir Mrljak; Peter David Eckersall Journal: Parasitol Res Date: 2021-08-24 Impact factor: 2.383
Authors: S J Viitanen; H P Laurila; L I Lilja-Maula; M A Melamies; M Rantala; M M Rajamäki Journal: J Vet Intern Med Date: 2013-12-18 Impact factor: 3.333
Authors: Anna Hillström; Jonas Bylin; Ragnvi Hagman; Karin Björhall; Harold Tvedten; Kristian Königsson; Tove Fall; Mads Kjelgaard-Hansen Journal: BMC Vet Res Date: 2016-10-28 Impact factor: 2.741
Authors: Arianna Maiolini; Meike Otten; Marion Hewicker-Trautwein; Regina Carlson; Andrea Tipold Journal: BMC Vet Res Date: 2013-02-04 Impact factor: 2.741